# Impact of Pinaverium Bromide on Bile Duct and Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography

> **NCT02882451** · NA · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Bile Duct Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** pinaverium bromide
- **DIETARY_SUPPLEMENT:** Vitamin C

## Key facts

- **NCT ID:** NCT02882451
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-07
- **Primary completion:** 2017-08
- **Final completion:** 2017-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02882451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02882451, "Impact of Pinaverium Bromide on Bile Duct and Pancreatic Duct Cannulation During Endoscopic Retrograde Cholangiopancreatography". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02882451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*